Michael Neumaier

9.9k citations
228 papers · 6.6k · 1 hit paper · h-index 42

Impact in

Papers in

Michael Neumaier

218 papers receiving 6.4k citations

Michael Neumaier's Hit Papers

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy 2003 · 606 citations
6060+7+15Years since publication200400600

Peers

Michael Neumaier
Comparison fields: 5 of 154
  • Radiology, Nuclear Medicine and Imaging 1.4k
  • Immunology and Allergy 311
  • Oncology 1.3k
  • Clinical Biochemistry 329
  • Cancer Research 564
Replace Christian C. Haudenschild with:
Christian C. Haudenschild United States
Eugene P. Frenkel United States
Erik A.L. Biessen Netherlands
Johan van der Vlag Netherlands
Swan N. Thung United States
Hans‐Anton Lehr Germany
Edo Vellenga Netherlands
Alberto Signore Italy
Satoru Todo Japan
Mitsune Tanimoto Japan
Michael Neumaier relative to Christian C. Haudenschild United States Christian C. Haudenschild's profile →
Citations per field
00.5×3.9×
Christian C. Haudenschild · 1×
Citations per year

Countries citing papers authored by Michael Neumaier

Since Specialization
Citations

This map shows the geographic impact of Michael Neumaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Neumaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Neumaier more than expected).

Fields of papers citing papers by Michael Neumaier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Neumaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Neumaier. The network helps show where Michael Neumaier may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Neumaier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Neumaier Line = papers co-authored together Michael Neumaier links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 228 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
Hit paper breakdown →
2003606
2 1994321
3 1993212
4 1996169
5 1996167
6 1988138
7 1994136
8 1999134
9 2007131
10 2012131
11 1998125
12
Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern.
1994120
13
Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas.
1995119
14 1988116
15 199592
16 201190
17 200989
18
Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
199086
19
Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques.
199883
20 200477

About Michael Neumaier

Michael Neumaier is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Immunology and Cancer Research, having authored 228 papers that have together received 6.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (23 papers), Radiopharmaceutical Chemistry and Applications (19 papers), Glycosylation and Glycoproteins Research (17 papers), Cancer Genomics and Diagnostics (17 papers), Molecular Biology Techniques and Applications (15 papers), Advanced Proteomics Techniques and Applications (14 papers), Genetic factors in colorectal cancer (12 papers) and Peptidase Inhibition and Analysis (10 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.4k citations), Immunology and Allergy (311 citations), Oncology (1.3k citations), Clinical Biochemistry (329 citations) and Cancer Research (564 citations). Michael Neumaier has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Christoph Wagener, Peter Findeisen, Markus Gerhard, Parviz Ahmad‐Nejad, Holger Kalthoff, John E. Shively, Jost B. Jonas, R. Jung, Hans Schreiber and Andreas Braun. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Clinical Chemistry, Clinica Chimica Acta, Journal of Biological Chemistry and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact